Psyence: Shroom with a view
Psyence Group — a Canadian listed psychedelics start-up with strong SA links — is eyeing a Nasdaq listing and may soon work its way to the JSE
If the JSE needs a potion to stimulate new listings then perhaps biotechnology companies with growth visions for the medical use of psilocybin and cannabis are just the fix?
The FM has been alerted to developments at Psyence Group — a start-up with connections to former FNB CEO Michael Jordaan and Sol Kerzner’s son Brandon that is listed on the Canadian Securities Exchange (CSE). The business is attracting attention from global investors ahead of a proposed listing on Nasdaq. The move comes at a time when the initial craving for cannabis stocks in North America has diminished markedly, and purveyors of psychedelics are wallowing in the hangover from Toronto-based Field Trip Health flipping out financially...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.